---
:type: http://www.assero.co.uk/BusinessForm#Form
:id: F-ACME_FAE
:namespace: http://www.assero.co.uk/MDRForms/ACME/V1
:label: Adverse Event Form (ACRO)
:extension_properties: []
:origin: ''
:change_description: ''
:creation_date: '2018-06-18T13:18:20+01:00'
:last_changed_date: '2018-06-18T13:18:20+01:00'
:explanatory_comment: ''
:registration_state:
  :namespace: http://www.assero.co.uk/MDRItems
  :id: RS-ACME_FAE-1
  :registration_authority:
    :id: RA-123456789
    :number: '123456789'
    :scheme: DUNS
    :owner: true
    :namespace:
      :namespace: http://www.assero.co.uk/MDRItems
      :id: NS-ACME
      :name: ACME Pharma
      :shortName: ACME
  :registration_status: Incomplete
  :administrative_note: ''
  :effective_date: '2016-01-01T00:00:00+00:00'
  :until_date: '2016-01-01T00:00:00+00:00'
  :current: false
  :unresolved_issue: ''
  :administrative_status: ''
  :previous_state: Incomplete
:scoped_identifier:
  :id: SI-ACME_FAE-1
  :identifier: F AE
  :version_label: ''
  :version: 1
  :semantic_version: 0.1.0
  :namespace:
    :namespace: http://www.assero.co.uk/MDRItems
    :id: NS-ACME
    :name: ACME Pharma
    :shortName: ACME
:completion: ''
:note: ''
:children:
- :type: http://www.assero.co.uk/BusinessForm#NormalGroup
  :id: F-ACME_FAE_G1
  :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
  :label: Common
  :extension_properties: []
  :ordinal: 1
  :optional: false
  :completion: ''
  :note: ''
  :children:
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G1_I1
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Site Number
    :extension_properties: []
    :ordinal: 1
    :note: ''
    :completion: ''
    :optional: false
    :datatype: string
    :format: '3'
    :question_text: 'Site #'
    :mapping: SITEID
    :children: []
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G1_I2
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Subject ID
    :extension_properties: []
    :ordinal: 2
    :note: ''
    :completion: ''
    :optional: false
    :datatype: string
    :format: '11'
    :question_text: 'Subject ID #'
    :mapping: USUBJID
    :children: []
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G1_I3
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Visit Date
    :extension_properties: []
    :ordinal: 3
    :note: ''
    :completion: ''
    :optional: false
    :datatype: date
    :format: ''
    :question_text: Visit Date
    :mapping: RFSTDTC
    :children: []
  :repeating: false
  :bc_ref: {}
- :type: http://www.assero.co.uk/BusinessForm#NormalGroup
  :id: F-ACME_FAE_G2
  :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
  :label: Adverse Events Occurred
  :extension_properties: []
  :ordinal: 2
  :optional: false
  :completion: ''
  :note: ''
  :children:
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G2_I1
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Adverse Event Experienced
    :extension_properties: []
    :ordinal: 1
    :note: |
      * No entries found for code list, parameters ['notation=NOYES'].
      * No entries found for code list, parameters ['notation=CLNOYES'].
    :completion: ''
    :optional: false
    :datatype: string
    :format: '1'
    :question_text: Has the subject experienced any adverse events
    :mapping: "[NO MAPPING]"
    :children: []
  :repeating: false
  :bc_ref: {}
- :type: http://www.assero.co.uk/BusinessForm#NormalGroup
  :id: F-ACME_FAE_G3
  :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
  :label: Adverse Event
  :extension_properties: []
  :ordinal: 3
  :optional: false
  :completion: ''
  :note: ''
  :children:
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G3_I1
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Adverse Event Number
    :extension_properties: []
    :ordinal: 1
    :note: ''
    :completion: ''
    :optional: false
    :datatype: integer
    :format: '3'
    :question_text: Event No.
    :mapping: AESPID
    :children: []
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G3_I2
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Adverse Event Term
    :extension_properties: []
    :ordinal: 2
    :note: ''
    :completion: ''
    :optional: false
    :datatype: string
    :format: '255'
    :question_text: Adverse event
    :mapping: AETERM
    :children: []
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G3_I3
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Adverse Event Start Date
    :extension_properties: []
    :ordinal: 3
    :note: ''
    :completion: ''
    :optional: false
    :datatype: date
    :format: ''
    :question_text: Start Date
    :mapping: AESTDTC
    :children: []
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G3_I4
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Adverse Event Stop Date
    :extension_properties: []
    :ordinal: 4
    :note: ''
    :completion: ''
    :optional: false
    :datatype: date
    :format: ''
    :question_text: Stop Date
    :mapping: AEENDTC
    :children: []
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G3_I5
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Adverse Event Continues
    :extension_properties: []
    :ordinal: 5
    :note: |
      * No entries found for code list, parameters ['notation=NOYES'].
      * No entries found for code list, parameters ['notation=CLNOYES'].
    :completion: ''
    :optional: false
    :datatype: string
    :format: '1'
    :question_text: Mark if event is still continuing
    :mapping: AEENRF
    :children: []
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G3_I6
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Adverse Event Serious
    :extension_properties: []
    :ordinal: 6
    :note: |
      * No entries found for code list, parameters ['notation=NOYES'].
      * No entries found for code list, parameters ['notation=CLNOYES'].
    :completion: ''
    :optional: false
    :datatype: string
    :format: '1'
    :question_text: Was event serious
    :mapping: AESER
    :children: []
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G3_I7
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Adverse Event Severity
    :extension_properties: []
    :ordinal: 7
    :note: |
      * No entries found in code list 'C66769' for item with submission value: '1' or preferred term: 'Mild'.
      * No entries found in code list 'C66769' for item with submission value: '2' or preferred term: 'Moderate'.
      * No entries found in code list 'C66769' for item with submission value: '3' or preferred term: 'Severe'.
    :completion: ''
    :optional: false
    :datatype: string
    :format: '1'
    :question_text: Severity
    :mapping: AESEV
    :children: []
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G3_I8
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Adverse Event Related
    :extension_properties: []
    :ordinal: 8
    :note: |
      * No entries found for code list, parameters ['notation=NOYES'].
      * No entries found for code list, parameters ['notation=CLNOYES'].
    :completion: ''
    :optional: false
    :datatype: string
    :format: '1'
    :question_text: Is there a reasonable possibility that the AE may have been caused
      by the study drug
    :mapping: AEREL
    :children: []
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G3_I9
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Adverse Event Action Taken
    :extension_properties: []
    :ordinal: 9
    :note: |
      * No entries found for code list, parameters ['notation=AEACTION'].
      * No entries found for code list, parameters ['notation=CLAEACTION'].
    :completion: ''
    :optional: false
    :datatype: string
    :format: '1'
    :question_text: Action taken with study drug
    :mapping: AEACN
    :children: []
  - :type: http://www.assero.co.uk/BusinessForm#Question
    :id: F-ACME_FAE_G3_I10
    :namespace: http://www.assero.co.uk/MDRForms/ACME/V1
    :label: Adverse Event Subject Outcome
    :extension_properties: []
    :ordinal: 10
    :note: |
      * No entries found for code list, parameters ['notation=AEOUT'].
      * No entries found for code list, parameters ['notation=CLAEOUTCOME'].
    :completion: ''
    :optional: false
    :datatype: string
    :format: '1'
    :question_text: Subject outcome
    :mapping: AEOUT
    :children: []
  :repeating: false
  :bc_ref: {}
